Jroundi Imane, Mahraoui Chafiq, Benmessaoud Rachid, Moraleda Cinta, Benjelloun BadrSououd, Bassat Quique
ISGlobal, Barcelona. Ctr International Health Research (CRESIB), Hospital clinic. Universitat de Barcelona, Calle Rosselló 132, 4°, PC 08036 Barcelona, Spain ; Laboratoire de santé publique et de médecine communautaire. Faculté de Médecine et de Pharmacie de Rabat, Université Mohamed V, Rabat, Morocco. AV Mohamed Belarbi El Alaoui Rabat Institut, BP 6203 Rabat, Morocco.
Hôpital d'Enfants de Rabat (HER), Centre Hospitalier Universitaire Ibn Sina, Rabat, Morocco. Rue Lamfadel Cherkaoui Rabat Institut, BP 6527 Rabat, Morocco.
Arch Public Health. 2015 Jun 15;73(1):28. doi: 10.1186/s13690-015-0076-x. eCollection 2015.
The burden of acute respiratory infections (ARI) among Moroccan children remains significant. However, scarce information is available regarding trends in its epidemiology and etiology, or regarding its associated prognostic factors. The purpose of this work was to review available data on the burden of ARI among children under five years of age in Morocco.
A systematic review was conducted for the period 1997-2014 using the PRISMA proposed methodology. Various online databases were screened, in addition to physical libraries of Moroccan medical schools, and official reports of the Moroccan Ministry of Health. Search queries in English and French languages included: Respiratory Tract Infections, pneumonia, epidemiology, etiology, microbiology, mortality and Morocco. The documents were included for analysis when they reported original data on the incidence, distribution, or a clinical description of the diseases or their etiology or described clinical management or national preventive strategies.
Thirty-two documents were included in the final analysis. 21 of which had been published. In 2012, ARI caused 13% of paediatric deaths, half of the consultations at health facilities and third of the paediatric admissions. The microorganisms more frequently identified among hospitalized children were Streptococcus pneumoniae (38%) and Haemophilus influenza type b (Hib) (15%). The MOH introduced Hib vaccines into the national immunization program (PNI) in 2007and the 13-valent vaccine against pneumococcus in 2010. The national first line antibiotics recommended for non-severe ambulatory treatment is Amoxicillin. Studies of antibiotic resistance showed from 1998 to 2008 a 22% increase in the rate of penicillin non-susceptibility among Streptococcus pneumoniae isolates. Viral respiratory infections and the role attributed to air pollution in the incidence of ARI have been poorly characterized.
Further efforts should be made towards the development of adequate surveillance programs to better clarify the epidemiology, etiology, antimicrobial susceptibility patterns and the effectiveness of the preventives and curatives strategies in place against paediatric ARIs in Morocco. Additionally, a holistical approach should be used to identify the heath determinants of ARIs among children.
摩洛哥儿童急性呼吸道感染(ARI)的负担仍然很重。然而,关于其流行病学和病因学趋势或相关预后因素的信息却很少。这项工作的目的是回顾摩洛哥5岁以下儿童ARI负担的现有数据。
采用PRISMA建议的方法对1997 - 2014年期间进行系统评价。除了摩洛哥医学院的实体图书馆和摩洛哥卫生部的官方报告外,还对各种在线数据库进行了筛选。用英语和法语进行的搜索查询包括:呼吸道感染、肺炎、流行病学、病因学、微生物学、死亡率和摩洛哥。当文件报告有关疾病的发病率、分布或临床描述、病因学,或描述临床管理或国家预防策略的原始数据时,将其纳入分析。
最终分析纳入了32份文件,其中21份已发表。2012年,ARI导致13%的儿童死亡、卫生机构一半的会诊以及三分之一的儿童住院。在住院儿童中最常发现的微生物是肺炎链球菌(38%)和b型流感嗜血杆菌(Hib)(15%)。摩洛哥卫生部于2007年将Hib疫苗引入国家免疫规划(PNI),并于2010年引入了针对肺炎球菌的13价疫苗。推荐用于非重症门诊治疗的国家一线抗生素是阿莫西林。抗生素耐药性研究表明,1998年至2008年期间,肺炎链球菌分离株中对青霉素不敏感率增加了22%。病毒性呼吸道感染以及空气污染在ARI发病率中的作用尚未得到充分描述。
应进一步努力制定适当的监测计划,以更好地阐明摩洛哥儿童ARI的流行病学、病因学、抗菌药物敏感性模式以及现有预防和治疗策略的有效性。此外,应采用整体方法来确定儿童ARI的健康决定因素。